Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Stem Cells for Dental Pulp Regeneration
NCT04040127Phase 2Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Sep 2019
- Primary completion
- Jan 2020
01
Overview
Phase 2, randomised, double-blind trial in irreversible pulpitis (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Regeneration of pulp. Planned start Sep 2019; status: withdrawn.
02
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04040127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04040127.